| 1 | [ozanimod cloridrato] | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 2 | [Ozanimod] | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 3 | [RPC1063 equiv to ozanimod HCI] | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 💬
|
| 4 | [RPC1063 equiv. to ozanimod HCI] | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 💬
|
| 5 | Other: Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod | [7] Acetate Acetate, Fingolimod, Glatiramer, Ozanimod (Ozanimodum), Ponesimod, Siponimod, Teriflunomide | [10] Fingolimod hydrochloride
Fingolimod hydrochloride
,
Glatiramer acetate
,
Fingolimod
,
Teriflunomide
,
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod),
Siponimod fumarate
,
Ponesimod
,
Siponimod
,
Fingolimod lauryl sulfate
💬
| [26] DHODH DHODH, HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [37] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Efferocytosis, Endocytosis, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
| 6 | Ozanimod | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 💬
|
| 7 | Ozanimod 0.5 mg | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 8 | Ozanimod 1 mg | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 9 | Ozanimod Cloridrato | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 10 | Ozanimod HCI | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 11 | Ozanimod HCL | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 💬
|
| 12 | Ozanimod hydrochloride | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 💬
|
| 13 | Ozanimod Oral Capsule | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 97 💬
|
| 14 | RPC1063 (equivalent to ozanimod | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 💬
|
| 15 | RPC1063 (equivalent to ozanimod HCl) | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 💬
|
| 16 | Select DMTs other than ozanimod | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 17 | ZEPIOSA® (Ozanimod) | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|
| 18 | ZEPOSIA® (ozanimod) | [1] Ozanimod Ozanimod (Ozanimodum) | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
(Ozanimod hydrochloride),
Ozanimod
(Ozanimod) 💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 97 97 💬
|